Suppression of GnRH secretion or action is the basis for a wide range of medical treatments, including that of uterine fibroids, endometriosis, and prostate cancer, as well as underpinning approaches to ovarian stimulation in assisted reproduction and indeed hormonal contraception. This evidence concerns the gene GNRH1 and uterine corpus leiomyoma.